Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v39-FR Version v8-EN
Language French English
Date Updated 2019-11-27 2019-02-20
Drug Identification Number 02424266 02424266
Brand name AURO-REPAGLINIDE AURO-REPAGLINIDE
Common or Proper name Repaglinide Repaglinide
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients REPAGLINIDE REPAGLINIDE
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A10BX A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-11 2019-01-11
Estimated end date 2019-03-30
Actual end date 2019-11-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Available - Limited stock
Health Canada comments